Renal Function Parameters, Serum Electrolyte Balance, and Haematological Profile in Beta-thalassaemia Patients with and without Kidney Injury
DOI:
https://doi.org/10.65204/Keywords:
Beta-thalassaemia, Renal Function, Glomerular Filtration Rate, Serum Electrolytes, Haematological ParametersAbstract
Beta-thalassaemia is associated with a spectrum of renal impairments, ranging from hyperfiltration to progressive dysfunction, depending on disease severity and treatment. Serum creatinine systematically underestimates renal dysfunction in this population owing to reduced skeletal muscle mass and altered erythropoiesis. This cross-sectional comparative study enrolled 180 participants in four groups: healthy controls (G1, n = 30), beta-thalassaemia with kidney injury (G2, n = 30), non-thalassemic kidney disease (G3, n = 30), and beta-thalassaemia without kidney injury (G4, n = 90). Renal indices (urea, creatinine, estimated glomerular filtration rate [eGFR]), serum electrolytes (Na+, K+, Cl−), and haematological parameters (RBC, WBC, haemoglobin [Hb]) were compared using one-way ANOVA with least significant difference (LSD) post-hoc testing. Pearson correlation coefficients were computed across all variables (n = 180). All parameters differed significantly among groups (P < 0.01). G4 showed paradoxically low creatinine (45.78 ± 1.46 µmol/L) and supranormal eGFR (122.85 ± 1.86 mL/min/1.73 m²), attributable to reduced creatinine generation from muscle depletion and glomerular hyperfiltration. Both thalassaemia groups demonstrated lower serum sodium, elevated WBC counts, and substantially reduced haemoglobin relative to healthy controls. Haemoglobin, meanwhile, was inversely correlated with potassium (r = −0.50) and positively correlated with RBC count (r = 0.77). Compared with non-thalassaemic chronic kidney disease (CKD), beta-thalassaemia produces a distinctive systemic profile. Creatinine-based assessments alone are insufficient for renal monitoring in this population; a multimodal strategy incorporating eGFR, serum electrolytes, and haematological profiling is recommended. Incorporating these varied metrics improves the accuracy of clinical evaluations significantly, Adopting a multimodal monitoring strategy is crucial for accurate risk stratification and safe clinical management in this population.